The effectiveness of vibration therapy for muscle peak torque and postural control in individuals with anterior cruciate ligament reconstruction: a systematic review and meta-analysis of clinical trials

Journal of Orthopaedics and Traumatology

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 5 Results of sensitivity analysis to assess the effects of each study on pooled WMD of outcomes

Outcome	No. of included studies		Pre-sensitivity analysis			Post-sensitivity analysis
Outcome	No. of included studies	Upper and lower of EF	95% CI	Pooled WMD	Excluded studies	95% CI	Pooled WMD
ML postural control (CE)	3^{26, 25, 30}	Upper	–1.48, –0.27	–0.87	Brunetti	–1.27, –0.26	–0.87
ML postural control (CE)	3^{26, 25, 30}	Lower			Fu	–2.18, 0.19	–0.99
AP postural control (CE)	4^{26, 25, 35, 30}	Upper	–0.2.78, 1.62	–0.58	Moezy	–2.51, 2.69	0.09
AP postural control (CE)	4^{26, 25, 35, 30}	Lower			Salvarani	–2.77, 1.62	–0.57
ML postural control (OE)	3^{26, 25, 24}	Upper	–1.26, 1.77	0.26	Brunetti	1.26, 2.33	1.80
ML postural control (OE)	3^{26, 25, 24}	Lower			Moezy	–1.40, 0.04	–0.68
AP postural control (OE)	3^{26, 25, 35}	Upper	–0.98, 0.01	–0.49	Salvarani	–0.98, 0.01	–0.48
AP postural control (OE)	3^{26, 25, 35}	Lower			Fu	–1.60, –0.12	–0.86
Hamstring PT	3^{26, 35, 31}	Upper	4.51, 20.83	12.67	All	4.51, 20.83	12.67
Hamstring PT	3^{26, 35, 31}	Lower			All	4.51, 20.83	12.67
Quadriceps PT	9^{23, 24, 26, 28,31, 32, 33, 34, 35}	Upper	–0.06, 0.29	0.11	da Costa	–0.01, 0.33	0.15
Quadriceps PT	9^{23, 24, 26, 28,31, 32, 33, 34, 35}	Lower			Salvarani	–0.09, 0.26	0.08

PT peak torque, AP anterioposterior, ML mediolateral, CE closed-eye, OE open-eye